… to assess the risk of different epithelial histological types of ovarian cancer in relation to …
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a …

… risk for breast or ovarian cancer in BRCA1/2 mutation carriers… non-carriers with positive family
history or other high-risk … OC was associated with breast cancer only for non-carriers (HR = …

… Finally, we created a combination of search terms as follows: ‘contraceptives, oral or oral
contraceptives’, and ‘breast neoplasm or breast cancer or ovarian neoplasm or ovarian cancer’, …

… Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation … factors
and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: …

… for how COCs prevent ovarian cancer, the process of ovarian cancer itself should be …
Immunosuppression (particularly HIV), tobacco use, parity and oral hormonal contraception use are …

… , while protective factors include parity, oral contraceptive pill (OCP) use and tubal ligation
(4). … risk factors for ovarian cancer differ between BRCA variant carriers and noncarriers. In …

… For example, if women diagnosed with PID were more likely to have taken oral contraceptives,
then we may have underestimated the association between PID and HGSC. Another …

… Parity is associated with decreased risk of invasive ovarian … , oral contraceptive use,
and history of breastfeeding. The same approach was used for histotype-specific analyses. …

… The use of oral contraceptive preparations (OCPs) has been found to be associated with
reduced ovarian cancer risk for both BRCA1 and BRCA2 mutation carriers (2–7). However, a …

… only in subpopulations according to different ethnicity, age group, parity, etc., we conducted
a cumulative estimate of these data for the entire study population. When the breast …